Literature DB >> 8982377

Histology of intestinal Whipple's disease revisited. A study of 48 patients.

A von Herbay1, M Maiwald, H J Ditton, H F Otto.   

Abstract

Whipple's disease is an infectious disorder with intestinal and extra-intestinal manifestations. We reinvestigated the intestinal histology in a series of 48 patients (10 females, 38 males; mean age 56.5 years, standard deviation of the mean +/- 11.2 years). A total of 126 biopsy samples, obtained prior to, during, and after therapy, were evaluated by light microscopy. In 43 patients (90%), histology was consistent with common descriptions, while it was uncommon in 3 patients (6%), and non-diagnostic in 2 patients (4%). During treatment, several alterations occurred. Apart from a continuous decrease in PAS-positive macrophages, the pattern of mucosal infiltration changed from diffuse to patchy. Moreover, the cytological aspects of PAS-positive macrophages changed substantially, and this change was used to propose four different subtypes. Initially, subtype 1 macrophages predominated (74%), but showed a gradual decrease within a few months of therapy. After 15 months, subtype 3 and subtype 4 macrophages predominated (< 80%). In 7 of 9 patients followed over long periods some subtype 3 or subtype 4 macrophages persisted. It is concluded that at diagnosis and during treatment the intestinal histology of Whipple's disease is heterogeneous. A few PAS-positive macrophages commonly persist at long-term follow-up. This and other features suggest the presence of a persistent immune defect.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982377     DOI: 10.1007/bf00198437

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

Review 1.  Whipple's disease: a rare disease revisited.

Authors:  Payam Afshar; David C Redfield; Philip A Higginbottom
Journal:  Curr Gastroenterol Rep       Date:  2010-08

Review 2.  Whipple's disease and "Tropheryma whippelii".

Authors:  F Dutly; M Altwegg
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

Review 3.  Diagnosis and treatment of Whipple's disease.

Authors:  R Singer
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

Review 4.  Whipple's disease.

Authors:  Federico Biagi; Lucia Trotta; Gino R Corazza
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

5.  A patient with cerebral Whipple disease with gastric involvement but no gastrointestinal symptoms: a consequence of local protective immunity?

Authors:  Harald Prüss; Juri Katchanov; Rolf Zschenderlein; Christoph Loddenkemper; Thomas Schneider; Verena Moos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-19       Impact factor: 10.154

Review 6.  [Tropheryma whipplei infection. Colonization, self-limiting infection and Whipple's disease].

Authors:  V Moos; C Loddenkemper; T Schneider
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

Review 7.  Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections.

Authors:  Ruben A V Dolmans; C H Edwin Boel; Miangela M Lacle; Johannes G Kusters
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

8.  Infection by Rhodococcus equi in a patient with AIDS: histological appearance mimicking Whipple's disease and Mycobacterium avium-intracellulare infection.

Authors:  D Hamrock; F H Azmi; E O'Donnell; W T Gunning; E R Philips; A Zaher
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

Review 9.  Changing paradigms in Whipple's disease and infection with Tropheryma whipplei.

Authors:  V Moos; T Schneider
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-02       Impact factor: 3.267

10.  Tropheryma whipplei Infection of an acellular porcine heart valve bioprosthesis in a patient who did not have intestinal Whipple's disease.

Authors:  Jens Dreier; Florian Szabados; Axel von Herbay; Thilo Kröger; Knut Kleesiek
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.